. The procedure consisted of ligating the left ureter and placing a serrefine clamp on the left renal artery for 2 hr under sterile conditions; 3 days later the right kidney was removed and the experiment was performed on the nonfiltering kidney the following day. To achieve a high control rate of renin secretion to facilitate study of an inhibitory response, each dog was sodium depleted by administering a diuretic (2 ml Mercuhydrin im) on the day of ureteral ligation and clamping of the renal artery; this was followed by the diuretic and a low-Na diet (<3 mEq/day) for the next 3 days. On the day of the experiment the dog was anesthetized with pentobarbital (15-30 rng/kg), polyvinyl catheters were placed in the femoral artery and vein, and an electromagnetic flow probe (Carolina Medical Electronics) was placed around the left renal artery through a flank incision. An 18-gauge needle was placed in the left renal vein to obtain renal venous blood samples and a Z-gauge needle was inserted into the left renal artery for intrarenal infusions.
Arterial pressure was measured with a Statham model P 23 Db pressure transducer.
Arterial pressure and renal blood flow were recorded on a Sanborn model 7700 recorder.
After surgical preparation normal saline was infused into the renal artery at 0.59 ml/min.
Sixty minutes later, two pairs of arterial and renal venous blood samples were collected for determining the control rate of renin secretion. In the first series of dogs, angiotensin II (Hypertensin-Ciba) in normal saline was infused into the renal artery at 0.59 ml/min and at a rate which was calculated to increase blood angiotensin II concentration by 7 ng/lOO ml. In a second group of experiments, the same protocol was followed except that the order of infusion of angiotensin II and ADl-l was reversed; the first experimental infusion contained ADH and the second was an angiotensin II infusion.
All blood removed for sampling was immediately replaced with an equal volume of fresh donor blood from a normal dog.
Analytzcal procedures. Arterial and renal venous blood samples for plasma renin activity determinations were collected in chilled tubes containing 0.1 ml of 10 % EDTA for each 10 ml of blood. The samples were immediately cooled in an ice bath and centrifuged in the cold for separation of plasma. Plasma samples were then stored frozen until they were processed for angiotensin generation by the method of Schneider et al. (12) . Two-milliliter samples of plasma were dialyzed against a phosphate buffer (PI-I 5.3) in the cold (4 C). Following dialysis, NaCl and diisopropylfluorophosphate (DFP) were added and the samples were incubated 37 C for 3 hr. Following incubation, the samples were placed in a boiling water bath for 10 min and then chilled in an ice bath. Each sample was diluted to 4 ml with phosphate buffer (pH 8.3), stirred and centrifuged, and the supernatant frozen until assayed. Samples were assayed by a pressor response in the pentobarbitalanesthetized, pentoliniurn-blocked rat with use of angiotensin II as a standard.
Renin secretion (ng angiotensin/ min) was calculated by subtracting arterial plasma renin activity from renal venous plasma renin activity and multiplying the difference by renal plasma flow. Hematocrits were determined in duplicate by a microhematocrit method. At the end of each experiment a solution of lissamine green dye was injected into the renal artery to verify the lack of glomerular filtration (2). Examination of the superficial renal tubules with a dissecting microscope revealed that dye failed to appear in the renal tubules in all of the dogs used in this study. In addition, recent studies from the laboratory have produced further evidence that this type of kidney preparation is nonfiltering (9). The data were analyzed for statistical significance by Student t test for paired differences. The apparent decrease in renal blood flow was the result of a large decrease in one of the five dogs in this experiment.
A small decrease in renal blood flow occurred in another dog but no change was detected in the three remaining animals; for the group, renal blood flow was unchanged (P > .05). Also, there were no consistent or significant changes in mean arterial pressure during angiotensin II infusion. After 30 min for a recovery period, renin secretion was 272 and 335 ng angiotensin/min but this change was not statistically significant. The infusion of ADH decreased renin secretion to 174 (P < 0.5) and 134 ng angiotensin/ min (P < .02) after 15 and 30 min of infusion (Fig. 1 ). There were no significant changes in renal blood flow or mean arterial pressure during ADH infusion. Thirty minutes after stopping the ADH infusion, renin secretion increased to an average of 503 ng angiotensin/min (P < .O 1). In a second group of experiments the same protocol was used and the order of infusion of the two peptides was reversed. These results are presented in Fig. 2 as small as 1 PI-J/ml significantly decreased plasma renin activity in sodium-deprived, conscious dogs.
The present results provide direct confirmation that ADH and angiotensin II inhibit renin secretion. In addition, since these peptides were infused in the nonfiltering kidney preparation, the results also show that inhibition of renin secretion occurred in the absence of a functional
